The combined market cap of Belgian SME biotech companies gained top position in the European ranking. The fact that the number of qualifying companies is 2 to 3 times smaller than in other European countries confirms the intrinsic quality of the Belgian public biotech sector.
Genkyotex develops therapeutic vaccines for women already infected by the human papillomavirus (HPV) before high grade lesions or cervical cancer occur.
Click on the chart to follow the daily exchange rate.
|Product||Indications and progress||Partner|
Benedikt Timmerman, CEO
Phone: 56 128 70 60
516 rue Pierre et Marie Curie, 31670 Labège, France